Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Kedudukan dalam Saham #27744
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Harga Saham
$2.15
Modal Pasaran
$30.83M
Perubahan (1 hari)
0.81%
Perubahan (1 tahun)
-61.85%
Negara
KR
Perdagangan IMBdx (461030)

Kategori

Nisbah P/S bagi IMBdx (461030)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini IMBdx, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk IMBdx dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH